NRGN and Alzheimer disease: Many of clinical studies support the findings that the levels of CSF Ng are higher in AD or MCI patients than those in healthy controls (HCs) or non-AD dementia patients (Fyfe, 2015; Hellwig et al., 2015; Kester et al., 2015; Portelius et al., 2015).